A recent review confirms that giving women at risk of premature birth a magnesium sulfate infusion can prevent their babies from developing cerebral palsy. The drug is inexpensive and recommended by the World Health Organization but is not consistently available worldwide. Implementation of this intervention has been successful in England, resulting in fewer cases of cerebral palsy. While the drug is cost-effective and life-changing, not all eligible mothers are receiving it, especially in low-resource settings. Further research is needed to optimize implementation and ensure that all eligible women are offered this potentially life-saving treatment globally.
Source link
Inexpensive drug can prevent cerebral palsy in premature babies, new review says
